Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model

Parasitology Research

Volumn 113, Issue 2, 2014, Pages 681-691

  Ali, Mohammad ^a   Afzal, Mohammad ^b   Verma, Meenakshi ^c   Bhattacharya, Shailja Misra ^c   Ahmad, F J ^d   Samim, Mohammad ^a   Abidin, M Z ^a   Dinda, A K ^e  

^a HAMDARD UNIVERSITY   (India)

^b Dabur Research and Development Centre   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

^d HAMDARD UNIVERSITY   (India)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; IVERMECTIN; NANOPARTICLE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUGIA MALAYI; BRUGIAN FILARIASIS; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ELECTROPHORETIC MOBILITY; FEMALE STERILIZATION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; MALE; MASTOMYS; MASTOMYS COUCHA; NANOENCAPSULATION; NONHUMAN; PARASITE CLEARANCE; PARASITE LOAD; PARTICLE SIZE; PRIORITY JOURNAL; RECURRENT DISEASE; SUSTAINED DRUG RELEASE; THERAPY EFFECT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALIA; BRUGIA; BRUGIA MALAYI; MASTOMYS COUCHA; MICROFILARIA (NEMATODE GENUS); ONCHOCERCIDAE; RODENTIA;

ANIMALS; BRUGIA MALAYI; DIETHYLCARBAMAZINE; FEMALE; FILARIASIS; FILARICIDES; IVERMECTIN; LACTIC ACID; MALE; MICROFILARIA; MURINAE; NANOCAPSULES; PARASITE LOAD; PARASITIC SENSITIVITY TESTS; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYVINYL ALCOHOL;

EID: 84903362677     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-013-3696-5     Document Type: Article

References (60)

1. Albanese A, Tang PS, Chan WCW (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1-16
2. Ash LR, Riley JM (1970) Development of sub periodic B. malayi in the jird (Meriones unguiculatus) with notes on infection in other rodents. J Parasitol 56:969-972
3. Ali M, Alam S, Ahmad S, Dinda AK, Ahmad FJ (2011) Determination of ivermectin stability by high-performance thin-layer chromatography. International J of Drug Development & Research 3:240-247
4. Ali M, Afzal M, Bhattacharya SM, Ahmad FJ, Dinda AK (2013a) Nanopharmaceuticals to target antifilarials: a comprehensive review. Expert Opin Drug Deliv 10(5):665-678
5. Ali M, Afzal M, Kaushik U, Bhattacharya SM, Ahmad FJ, Dinda AK (2013b) Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences. J Drug Target. doi: 10.3109/1061186X.2013. 832766
6. Ali M, Afzal M, Verma M, Bhattacharya SM, Ahmad FJ, Dinda AK (2013c) Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi. Parasitol Res 112(8):2933-2943
7. Anitha K, Shenoy RK (2001) Treatment of lymphatic filariasis: current trends, continuing medical education. Indian J Dermatol Venereol Leprol 67(2):60-65
8. Bajpai P, Vedi S, Owais M, Bhattacharya SM (2005) Use of liposomized tetracycline inelimination of Wolbachia endobacterium of human lymphatic filariid Brugia malayi in a rodent model. J Drug Target 13:375-381
9. Bajpai P, Srivastava K, Shakya S, Saxena PN, Bhattacharya SM (2007) Improvement in the efficacy of existing combination of antifilarials by inclusion of tetracycline in rodent model of brugian filariasis. Current Science 92(5):655-658
10. Bassi P, Kaur G (2010) pH modulation: a mechanism to obtain pH-independent drug release. Expert Opin Drug Deliv 7:845-57
11. Bikram M, West JL (2008) Thermo-responsive systems for controlled drug delivery. Expert Opin Drug Deliv 5:1077-1091
12. Bawa P, Pillay V, Choonara YE (2009) Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater 4:234-245
13. Bhatt AD, Pethe AM (2010) Nanotechnology: a promising drug delivery for poorly water soluble drugs. Journal of Pharmacy Research 3:817-848
14. Campbell WC (1983) Ivermectin: a potent new antiparasitic agent. Science 221:823-828
15. Chrastina A, Massey KA, Schnitzer JE (2011) Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3(4):421-437
16. Dangi A, Dwivedi V, Vedi S, Owais M, Misra-Bhattacharya S (2010) Improvement in the antifilarial efficacy of doxycycline and rifampicin by combination therapy and drug delivery approach. J Drug Target 18(5):343-350
17. Danhier F, Lecouturier N, Vromana B, Jérôme C, Marchand-Brynaert J, Ferond O, Préat V (2009) Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J of Controlled Release 133:11-17
18. Date AA, Joshi MD, Patravale VB (2007) Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 10:505-521
19. Fox LM (2006) Ivermectin: uses and impact 20 years on. Curr Opin Infect Dis 19(6):588-593
20. Fonseca C, Simoes S, Gaspar RE (2002) Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Controlled Release 83(2):273-286
21. Danhier F, Ansorena E, Silva JM, Coco R, Breton A, Préat V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505-522
22. Geary TG (2005) Ivermectin 20 years on: maturation of a wonder drug. TRENDS in Parasitology 21(11):45-55
23. Goa KL, McTavish D, Clissold SP (1991) Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs 42(4):640-658
24. Haldar KM, Haldar B, Chandra G (2013) Fabrication, characterization and mosquito larvicidal bioassay of silver nanoparticles synthesized from aqueous fruit extract of putranjiva, Drypetes roxburghii (Wall.). Parasitol Res 112(4):1451-1459
25. Jayaseelan C, Rahuman AA, Rajakumar G, Kumar ST, Kirthi AV, Marimuthu S, Bagavan A, Kamaraj C, Zahir AA, Elango G (2012) Efficacy of plant-mediated synthesized silver nanoparticles against hematophagous parasites. Parasitol Res 111(2):921-933
26. Kumar VK, Govindarajan M, Rajeswary M (2013a) Green synthesis of silver nanoparticles using Sida acuta (Malvaceae) leaf extract against Culex quinquefasciatus, Anopheles stephensi, and Aedes aegypti (Diptera: Culicidae). Parasitol Res 112(12):4073-4085
27. Kumar AN, Jeyalalitha T, Murugan K, Madhiyazhagan P (2013b) Bioefficacy of plant-mediated gold nanoparticles and Anthocepholus cadambaon filarial vector, Culex quinquefasciatus (Insecta: Diptera: Culicidae). Parasitol Res 112(3):1053-1063
28. Kirthi AV, Rahuman AA, Rajakumar G, Marimuthu S, Kumar ST, Jayaseelan C, Velayutham K (2012) Acaricidal, pediculocidal and larvicidal activity of synthesized ZnO nanoparticles using wet chemical route against blood feeding parasites. Parasitol Res 109(2):461-472
29. Khanna VG, Kannabiran K, Rajakumar G, Rahuman AA, Kumar TS (2011) Biolarvicidal compound gymnemagenol isolated from leaf extract of miracle fruit plant, Gymnema sylvestre (Retz) Schult against malaria and filariasis vectors. Parasitol Res 109(5):1373-1386
30. Kayser O, Kiderlen A, Croft S (2003) Natural products as antiparasitic drugs. Parasitol Res 90:55-62
31. Uhrich KE (1999) Polymeric systems for controlled drug release. Chem Rev 99:3181-3198
32. Lakshmi V, Srivastava S, Mishra SS (2009) In vitro and in vivo antifilarial potential of marine sponge, Haliclona exigua (Kirkpatrick) against human lymphatic filarial parasite Brugia malayi. Parasitol Res 105(5):1295-1301
33. Misra N, Sharma M, Raj K (2007) Chemical constituents and antifilarial activity of Lantana camara against human lymphatic filariid Brugia malayi and rodent filariid Acanthocheilonema viteae maintained in rodent hosts. Parasitol Res 100:439-448
34. Martin RJ, Kusel JR, Robertson SJ, Minta A, Haugland RP (1992) Distribution of a fluorescent ivermectin probe, bodipy ivermectin, in tissues of the nematode parasite Ascaris suum. Parasitol Res 78(4):341-348
35. Mu L, Feng SS (2003) A novel controlled release formulation for the anticancer drug Paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86:33-48
36. Merisko-Liversidge EM, Liversidge GG (2008) Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol 36:43-48
37. Manish G, Vimukta S (2011) Targeted drug delivery system: a review. Res J Chem Sci 2:135-141
38. Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK (2007) Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimization and in vitro characterization. Eur J Pharm Biopharm 68:513-525
39. Muthu MS, Singh S (2009) Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine 4(1):105-118
40. Mahmud A, Xiong X, Montazeri H (2007) Polymeric micelles for drug targeting. J Drug Target 15:553-584
41. Misra S, Chaterjee RK, Sen AB (1984) The response of Litomosides carinii to antifilarial agents in cotton rats Sigmodon hispidus and multimammate rat. Indian J of Med Res 79:749-752
42. Nayak A, Gayen P, Saini P (2012) Molecular evidence of curcumin induced apoptosis in the filarial worm Setaria cervi. Parasitol Res 111:1173-1186
43. Oyibo W, Fagbenro-Beyioku A (1997) Community response to repeated annual ivermectin treatment of onchocerciasis in Nigeria. Parasitol Res 88(7):704-707
44. Owais M, Misra-bhattacharya S, Haq W, Gupta CM (2003) Immunomodulator tuftsin augments antifilarial activity of diethylcarbamazine against experimental brugian filariasis. J Drug Target 11:247-251
45. Piessens WF, Beldekas M (1979) Diethylcarbamazine enhances antibody mediated cellular adherence to Brugia malayi microfilariae. Nature 282:845-847
46. Pourmand A, Pourmand MR, Wang J et al (2012) Application of nanomedicine in emergency medicine; point-of-care testing and drug delivery in twenty-first century. DARU J of Pharm Sci 20(1):20-26
47. Priscyla D, Marcato DN (2008) New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol 8:1-14
48. Romero EL, Morill MJ (2008) Drug delivery systems against leishmaniasis? Still an open question. Expert Opin Drug Deliv 5(7):805-882
49. Rao UR, Chandrashekar R, Subrahmanyam D (1990) Effect of ivermectin on filariae of Mastomys natalensis. Parasitol Res 76(6):521-525
50. Ros-Moreno RM, Moreno-Guzmán MJ, Jiménez-González A, Rodríguez-Caabeiro F (1999) Interaction of ivermectin with γ-aminobutyric acid receptors in Trichinella spiralis muscle larvae. Parasitol Res 85(4):320-323
51. Subarani S, Sabhanayakam S, Kamaraj C (2013) Studies on the impact of biosynthesized silver nanoparticles (AgNPs) in relation to malaria and filariasis vector control against Anopheles stephensi Liston and Culex quinquefasciatus Say (Diptera: Culicidae). Parasitol Res 112(2):487-499
52. Soni N, Prakash S (2012a) Efficacy of fungus mediated silver and gold nanoparticles against Aedes aegypti larvae. Parasitol Res 110(1):175-184
53. Soni N, Prakash S (2012b) Fungal-mediated nano silver: an effective adulticide against mosquito. Parasitol Res 111(5):2091-2098
54. Said DE, Samad LM, Gohar YM (2012) Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents. Parasitol Res 111(2):545-554
55. Soll MD, Carmichael HI (1998) Efficacy of injectable ivermectin against the itch mit (Psorergates ovis) of sheep. Parasitol Res 75(1):81-82
56. Singh U, Misra S, Murthy PK, Katiyar JC, Agarwal A, Sircar AR (1997) Immunoreactive molecules of Brugia malayi and their diagnostic potential. Immunother Infect Dis 8:207-212
57. Santos-Magalhães NS, Mosqueira VC (2010) Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev 62:560-575
58. Sahni JK, Baboota S, Ali J (2011) Promising role of nanopharmaceuticals in drug delivery. Pharma Times 10:34-45
59. Takakura Y (1996) Development of drug delivery systems for macromolecular drugs. Article in Japanese 116(7):519-532
60. World Health Organization (2010) WHO global programme to eliminate lymphatic filariasis progress report for 2000-2009 and strategic plan 2010-2020. World Health organization, Geneva